Halozyme Therapeutics (HALO) Tops Q2 EPS by 30c ; Offers Guidance

Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 30c ; Offers Guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 98.66 -2.01 (2%)
Previous Close $100.67    52 Week High $18.39 
Open $100.35    52 Week Low $6.96 
Day High $100.83    P/E N/A 
Day Low $98.13    EPS $-0.58 
Volume 1,656,627